Trial Profile
A comparative study of inhaled ciclesonide versus placebo in children with asthma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Sep 2021
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms RAINBOW
- Sponsors ALTANA Pharma; Nycomed Pharma GmbH
- 04 May 2012 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.
- 07 Jul 2010 Results published in Respiratory Medicine.
- 16 Sep 2009 Efficacy and quality of life results were presented at the 19th Annual Congress of the European Respiratory Society.